Compare FERG & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FERG | KVUE |
|---|---|---|
| Founded | 1887 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Miscellaneous | Specialty Chemicals |
| Sector | Miscellaneous | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.8B | 33.1B |
| IPO Year | N/A | 2023 |
| Metric | FERG | KVUE |
|---|---|---|
| Price | $227.01 | $17.03 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 13 |
| Target Price | ★ $250.07 | $20.31 |
| AVG Volume (30 Days) | 1.7M | ★ 39.0M |
| Earning Date | 12-09-2025 | 02-05-2026 |
| Dividend Yield | 1.55% | ★ 4.88% |
| EPS Growth | 18.63 | ★ 35.31 |
| EPS | ★ 9.88 | 0.75 |
| Revenue | ★ $31,159,000,000.00 | $15,006,000,000.00 |
| Revenue This Year | $7.38 | N/A |
| Revenue Next Year | $5.90 | $2.81 |
| P/E Ratio | $23.26 | ★ $22.75 |
| Revenue Growth | ★ 4.92 | N/A |
| 52 Week Low | $146.00 | $14.02 |
| 52 Week High | $256.93 | $25.17 |
| Indicator | FERG | KVUE |
|---|---|---|
| Relative Strength Index (RSI) | 39.13 | 53.22 |
| Support Level | $225.44 | $16.93 |
| Resistance Level | $230.99 | $17.48 |
| Average True Range (ATR) | 5.67 | 0.25 |
| MACD | -0.85 | -0.05 |
| Stochastic Oscillator | 16.83 | 39.43 |
Ferguson distributes plumbing and HVAC products to North American repair, maintenance and improvement, new construction, and civil infrastructure markets. It serves over 1 million customers and sources products from 36,000 suppliers. Ferguson engages customers through approximately 1,800 North American branches, over the phone, online, and in residential showrooms. According to Modern Distribution Management, Ferguson is the largest plumbing distributor and second-largest HVAC distributor (next to Watsco) in North America. The firm sold its UK business in 2021 and is now solely focused on the North American market.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.